What You Should Know:
– PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its digital…
Continue Reading
Sora Neuroscience, a brain AI software company, announced it received FDA clearance for its Cirrus brain mapping software, which is used for helping neurosurgeons make clinical decisions. Cirrus uses functional magnetic resonance imaging (fMRI) to generate…
Continue Reading
Breakthrough AI Technology Transforms Portable Brain Imaging
Hyperfine Inc., the pioneering company behind the world’s first FDA-cleared AI-powered portable MRI system, has achieved another significant milestone with FDA clearance of its groundbreaking Optive AI software….
Glucose monitoring specialist Dexcom is expanding its partnership with health-tracking ring maker Oura to provide Stelo users and ring wearers with metabolic health features, including meal insights and glucose data. Stelo provides individuals 18 and…
Continue Reading
Revolutionary Digital Tomosynthesis System Approved
NANO-X IMAGING LTD has achieved a significant milestone with FDA 510(k) clearance for their innovative Nanox.ARC X multi-source digital tomosynthesis system. The approval process was remarkably swift, taking less than…
Extended Wear CGM Innovation Redefines Diabetes Management
Dexcom has reached a significant milestone with FDA clearance for its G7 15-Day continuous glucose monitoring system for adults 18 and older. This next-generation device extends wear time…
TytoCare lung exam
What You Should Know:
– TytoCare, a pioneering virtual care company dedicated to delivering accessible, high-quality primary care from the comfort of home announced the company has become the first in the world…
Continue Reading
What You Should Know:
– Click Therapeutics, Inc. (“Click”), a leader in the rapidly evolving field of prescription medical treatments, encompassing both prescription digital therapeutics (PDTs) and software-enhanced drug™ therapies has received FDA marketing authorization…
Continue Reading
Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational diabetes. G7 15 Day,…
Continue Reading
Remote patient monitoring startup Sibel Health closed a $30 million Series C funding round on Thursday, bringing its total funding amount to $63 million.
The company — founded in 2018 as a spinout of Northwestern…
Continue Reading
